Human resting B lymphocytes enter a state of sustained proliferation when incubated with both mouse fibroblastic L cells stably expressing FcyRII/CDw32 and anti-CD40 antibodies . We have explored the effects of 11 recombinant human cytokines (CKs) on induced cell proliferation and immunoglobulin (Ig) production. Interleukin 4 (IL4) was the only CK able to enhance anti-C1340-induced B cell multiplication as measured by enumeration of viable cells, and interferon y (IFN-y) further stimulated this induced proliferation. IL4 enhanced the production of IgM and IgG by B cells and induced them to produce IgE. Combinations of 114 and 11,2 resulted in the production of large amounts of IgM and IgA. Interestingly, IFN-'y did not inhibit the production of IgE by cells stimulated with anti-CD40 and IL4. None of the tested CK combinations resulted in the production of large quantities of IgG. Therefore, this new culture system represents a unique model to study isotype regulation in highly purified human B lymphocytes, in addition to allowing the generation of long-term factor-dependent human B cell lines.
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T he maturation of resting B lymphocytes into Ig-secreting cells is a highly regulated phenomenon, thought to be coupled to considerable proliferation, which requires the participation of antigen (Ag),' T cells, and probably accessory cells (3) acting through cell-cell interactions via specific membrane Ags and through the release of cytokines (CKs). An approach to understanding the phenomena involved in B cell activation has been made possible through the availability of polyclonal activators including antibodies to surface Ags (4) and recombinant CKs (3) . These studies have shown that antibodies against the B cell Ag receptors (sIg) as well as other non-Ig molecules can deliver activation signals to B cells. In particular, the CD40 molecule has recently emerged as a functionally important B cell surface Ag (5, 6) . The CD40 Ag is a 277-amino acid glycoprotein whose 172-amino acid extracellular domain has homology with the nerve growth factor receptor (7) and the 55-and 80-kD TNF receptors (8) . Soluble anti-CD40 strongly enhances [3H]TdR uptake in costimulated B cells and activates resting B cells as determined by cell size increase (5, 6) . More recently, we have shown that anti-CD40 antibodies presented on irradiated transfected L cells stably expressing FcyRII/CDw32 induce a strong and long-lasting proliferation of human B lymphocytes, which allowed us to generate factor-dependent human B cell lines free of EBV infection (9).
1 Abbreviations used in this paper. Ag, antigen; CK, cytokine; GM, granulocyte/macrophage; rh, recombinant human.
Part of this work has been presented in Abstract forms at the 1990 UCLA Symposium on B lymphocyte development, March 31-April 6, Park City, UT (1, 2) .
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The present work is aimed at studying the effects of many different recombinant CKs on the proliferation and Ig production of human B cells activated with anti-CD40. We show that 114 is the sole CK able to boost the anti-CD40-induced expansion of B lymphocytes and that IFN-y enhances this effect . Furthermore, IL4 induces anti-CD40-activated B cells to produce IgE, and combinations of 114 and I1r2 induce the production of large amounts of IgM and IgA.
Materials and Methods
Reagents. The anti-CD40 mAb 89 was produced in the laboratory (6) . The CDw32/FcyRII-transfected Ltk -cell line (CDw32 L cells) was kindly provided by Dr. K. Moore (DNAX, Palo Alto, CA) (10) . Cell phenotype was determined using FITCconjugated mAbs originating from Becton Dickinson & Co. (Mountain View, CA). The F(ab')2 fragments of goat anti-human IgD and IgM were from KallestadLaboratories, Inc. (Austin, TX). Cultures were carried out in modified Iscove's medium as detailed previously (11) .
Cell Preparations and Cell Cultures. B cells were isolated from tonsils as described earlier (12) . The isolated population expressed >98% CD19 or CD20 (B cells) and <1% CD2 (T cells) or CD14 (monocytes). Proliferation assays were performed in 96-well V-shaped microtiter plates (CEB, Nemours, France) in which 2.5 x 10 3 irradiated (7,000 rad) CDw32 L cells were added. 2.5 x 10°puri-fied B cells were then added to cultures. Cells were pulsed with 1 pCi ['H]TdR usually at day 3 and 7.
[3H]TdR uptake was measured by standard liquid scintillation counting techniques after harvesting. In most experiments, 5 x 105 B cells in 1 ml were cultured on 2.5 x 10' irradiated CDw32 L cells in 24-well plates, for Ig production. Supernatants were harvested after 10 d and Ig levels were determined by ELISA. Ig levels were also determined in the supernatants of cells that had been split at various time in-tervals. The production of IgG, IgM, IgA, and IgE was measured in standard ELISA as described elsewhere (11) .
Cytokines . Each of the tested CKs was used over a wide range of concentrations . Purified recombinant human (rh) II,1a (108 U/mg) was purchased from Genzyme (Boston, MA) and was usually used at 25 U/ml (2.5-150 U/ml) . Purified rhIL2 (3 x 106 U/ml) and rhIFN-y (107 U/mg) were purchased from Amgen Biologicals (Thousands Oaks, CA) and were, respectively, used at 20 U/ml (1-50 U/ml) and 500 U/ml (25-1,250 U/ml). Purified rhIL5 was provided by R. Coffman (DNAX) . It was usually used at 15 ng/ml, which represents five times the concentration required for optimal growth and differentiation of human eosinophil precursors . Purified rhII,3 (5 x 106 U/mg) and granulocyte/macrophage (GM)-CSF (2 x 106 U/mg) were'provided by S. Tindall (Schering-Plough Research, Bloomfield, NJ) and were usually, respectively, used at 10 ng/ml (1-50 ng/ml) and 100 ng/ml (10-250 ng/ml), which were saturating for the growth of hematopoietic precursors in liquid cultures or in colony assays performed in semisolid medium. Purified rhIL4 (derived from Escherichia coli ; 107 U/mg) was provided by P. Trotta (Schering-Plough Research) . In most experiments, 11,4 was used at 100 U/ml (0.1-1,750 U/ml), which provides maximal stimulation of B cell growth in these culture conditions . Purified E . coli-derived rhIFNa2b (2 x 109 U/ml; ScheringPlough Research) was usually used at 250 U/ml (50-1,000 U/ml). Purified rhTNF-a (2 x 107 U/mg; Genzyme) was usually used at 5 ng/ml (1-20 ng/ml) . Purified rhIIx6 (10 7 U/mg ; Genzyme) was usually used at 5 ng/ml (0.25-25 ng/ml) . Human 11,7, purified from Cos 7 supernatant, was provided by F. Lee and J . Wideman (DNAX) . It was usually used at 25 U/ml (1-100 U/ml), one unit being defined as the concentration inducing the half-maximal proliferation of the murine pre-B clone K.
Results
Proliferation of Anti-CD40-activated B Cells in Response to CKs . To study whether CKs would costimulate with crosslinked anti-CD40 to induce B cell proliferation, purified resting B cells were cultured on CDw32 L cells with 0 .5 pg/ml mAb 89 with or without 11 different recombinant CKs, each of them used at various concentrations. [ 3H]TdR uptake was measured at day 3 and 7 . Results illustrated in Fig. 1 were pooled from several independent experiments performed under exactly the same conditions (at day 7) and show the CK concentration that was found to be optimal in this assay. Results obtained with IL4 alone represent the mean of 23 different experiments performed over an 18-mo period. The other CKs used alone or in combination with IL4 have been tested in three to five independent experiments. As illustrated in Fig.  1 A, IL4 strongly potentiated B cell proliferation . As shown in Fig. 2 A, the 1L4-induced [3 H]TdR uptake was optimal at -100 U/ml, but concentrations as low as 2.5 U/ml displayed significant activity. IL1ca, 11,6, and IFN-,y were also found to enhance [3 H]TdR uptake, but it was always lower than that observed in IL4. Their proliferative effects were dose dependent and were maximal at, respectively, 25 U/ml, 2 ng/ml, and 250 U/ml (data not shown) . IL2 and IL3 also weakly enhanced [3H]TdR uptake, but I1,5, 11,7, TNF-ca, GM-CSF, and IFN-a2b did not.
As 11L4 was reproducibly a strong enhancer of B cell growth, we tested whether the other CKs would modulate its effects.
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Anti-CD40 Activation of B Lymphocytes .1a = 25 U/ml ; IL2 = 20 U/ml; IL3 = 10 ng/ml ; IL4 = 100 U/ml ; 11,5 = 15 ng/ml ; 11,6 = 5 ng/ml ; IIT7 = 25 U/ml; TNF-a = 5 ng/ml ; GM-CSF = 100 ng/ml ; IFN-a2b = 500 IU/ml ; IFN-,y = 250 U/ml .
Ma and IFN-,y enhanced the [3H]TdR uptake induced by IL4 (Fig. 1 B) , and maximum stimulation was obtained with 25 and 250 U/ml, respectively. IL2,1W, and IL6 also slightly without mAb 89, and with or without recombinant CKs, were tested for their ability to produce Igs . As illustrated in Table 1 , crosslinking of CD40 did not result in significant Ig production, although supernatants of cells cultured with mAb 89 contained a few-fold more IgM and IgG than those of cells cultured without mAb 89. ILlcx, IL-2, IL-3, IL5, IL6, and IFN-y only marginally altered Ig production . However, IL4 consistently stimulated IgM and IgG production . The most striking finding was the IL4-induced production of IgE . As shown in Fig. 2 B, the 1174-induced increase of Ig production was dose dependent, and the plateau was obtained for -100 U/ml IL4 for all three isotypes (data not shown, for IgM). The concentration of IL-4 inducing a halfmaximal response was practically the same for the three isotypes (-10 U/ml for IgG and IgM; -40 U/ml for IgE) . B cells cultured for 21 d with anti-CD40 and 11,4 continuously produced the four isotypes (Table 2) .
We also tested whether the IL4-induced Ig production could be modulated by other CKs (Table 1) . ILlct, IL-3, IL-5, IL6, and IFN-y only weakly modulated Ig production induced by 114. Note in particular the lack of inhibitory effect of IFN-y on IL4-induced IgE production . Most interestingly, combinations of IL2 and 1174 resulted in production of IgM and IgA. As shown in Fig. 3 , the induced IgM and IgA productions were a function of IL2 concentration . Recently, we have reported that anti-CD40 antibodies presented on FcyRII/CDw32-transfected L cells can induce the proliferation of resting B lymphocytes (9) . This system is unique in that it is the first one that allows an increase of the total number of seeded human B cells . The present study was aimed at determining how CKs affect the proliferation and dilerentiation of these anti-CD40-activated B cells. Among 11 tested recombinant CKs (ILlce to 7, GM-CSF, TNF-a, IFN-oz2b and IFN-y), only IIA was found to strongly costimulate with anti-CD40 to induce B cell proliferation as measured both by [3 H ]TdR uptake and cell counts . Unlike what was previously demonstrated with anti-IgMactivated B cells where IL4 appears to act as a short-term growth factor (12), the activating property of IL4 on anti-CD40-activated B cells was long lasting . ILlcac, IL6, and IFN-y were found to enhance [ 3H]TdR uptake, but the effect was not sufficient to result in increased cell counts . IFN-y, and to a lesser extent ILla, were found to enhance B cell proliferation induced by IL4 and anti-CD40 . The stimulatory effect of IFN-y on IL4/anti-CD40-induced B cell proliferation is in accordance with our earlier results showing that IFN-y enhances the IL-4-induced proliferation of B cells costimulated with anti-IgM with or without IL4 (12, 13) . It is worth pointing out that IL5 failed to enhance the proliferation of anti-CD40-activated B cells and, therefore, in contrast to murine IL-5 (14) , human IIT5 has never scored positive in any of the assays measuring B cell proliferation (15) . Likewise, TNF-a and IFN-oz failed to induce the proliferation of anti-CD40-activated B cells, whereas they have been shown to induce the proliferation of B lymphocytes activated through their Ag receptors (16, 17) . Also of interest is the virtual lack of growth-promoting activity of IL-2 on anti-CD40-activated B cells, whereas it is at least as potent and often more potent than IL4 in inducing [3 H]TdR uptake in B cells stimulated with anti-IgM or Staphylococcus aureus Cowan (18) . IL3 was found repeatedly to provide a small proliferation signal to anti-CD40-activated B cells, which we also found with B cells costimulated with anti-IgM (T Defrance and J. Banchereau, unpublished observations) . Finally, as observed with B cells stimulated through their Ag receptor, IL-7 and GM-CSF were unable to induce the proliferation of anti-CD40-activated B cells.
B cells activated with anti-CD40 were found to produce relatively little IgM, IgG, and IgA. Whereas IL1a, IL2, 11,3, IL5, IL6, and IFN-y did not enhance the Ig production of proliferating B cells, 11,4 was able to enhance IgM and IgG production and to induce the production of large amounts of IgE. This contrasts with previous studies showing the necessary role of T cells and monocytes in IL4-induced differentiation of B cells to IgE production (19) (20) (21) . However, a direct capacity of IL4 to induce purified human B cells to produce IgE was recently described (22) where combined addition of EBV and IL4 results in EBV transformed B cell lines producing IgE . In our present system, we have been able to rule out a possible role for EBV by various means (9) . The half-maximal concentrations of IL4-inducing production of IgM, IgG, and IgE were similar. This contrasts with the concentrations of 114 required to induce LPS-activated murine B cells to produce IgE that are higher than those necessary to induce IgG (23) . Interestingly, IFN-y appears unable to inhibit the 114-induced IgE production by anti-CD40-activated human B cells, at variance with the EBV system (22) , where IFN-y can block the IL4-independent generation ofIgE-producing EBV cell lines . It also differs from the IL-4-induced IgE production by mouse LPS-activated B cells, which is also inhibited by IFN-y (24) . The lack of inhibitory activity of IFN-y in I1,4-induced IgE production has, however, been observed with cord blood B cells (25) . Taken together, these data suggest that IFN-y may inhibit I174-induced IgE production by adult mononuclear cells in an indirect fashion . Our present observation suggests that triggering of CD40 may represent an important event in the 11,4-induced IgE production . It remains to be established whether the observed production of IgE results from the expansion of IgEcommitted B cells or from an IL4/anti-CD40-induced switch . We presently favor the latter hypothesis, as preliminary experiments have shown that naive IgD' B cells do indeed produce IgE under these culture conditions . Our present finding raises the question as to whether the IgE production observed in an allogeneic T-B cell interaction (21, 26, 27) or in the 114 activation of mononuclear cells (19, 20, 27) involves triggering of the B cell CD40 Ag.
The combination of IL4 and IL-2 resulted in a strong IgM Ag has been shown to display an important homology with nerve growth factor receptor (7) and TNF receptors (8) .
